More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia

Leukemia

Volumn 16, Issue 11, 2002, Pages 2249-2252

  Huh, Y O ^a   Jilani, I ^a   Estey, E ^a   Giles, F ^a   Kantarjian, H ^a   Freireich, E ^a   Albitar, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute myelogenous leukemia; Apoptosis; Myelodysplastic syndrome; Refractory anemia with excess blasts in transformation

Indexed keywords

LIPOCORTIN 5;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BLAST TRANSFORMATION; BONE MARROW BIOPSY; CANCER STAGING; CELL DEATH; CONTROLLED STUDY; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOCHONDRION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; WORLD HEALTH ORGANIZATION;

EID: 0036848438     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402704     Document Type: Article

References (14)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Sultan C. The French-American-British (FAB) Co-operative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue. Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
3. Yoshida Y. Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 1993; 7: 144-146.
4. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268-276.
5. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995; 48: 143-154.
6. Rajapaksa R, Ginzton JP, Rott LS, Greenberg PL. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 1996; 88: 4275-4287.
7. Merchant SH, Gonchoroff NJ, Hutchison RE. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes. Cytometry 2001; 46: 28-32.
8. Irvine AE, Magill MK, Somerville LE, McMullin ME. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia. Exp Hematol 1998; 26: 435-439.
9. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood 2000; 96: 3932-3938.
10. Albitar M, Beran M, O'Brien S, Kantarjian H, Freireich E, Keating M, Estey E. Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia. Blood 2000; 96: 372-373.
11. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidyl serine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Meth 1995; 164: 39-51.
12. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
13. Suzuki K, Kostin S, Person V, Elsasser A, Schaper J. Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 2001; 33: 983-994.
14. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic action 5, 5′, 6, 6′ -tetrachloro-1,1′,3,3′-tetraethylbenzimidazoicarbocyanine